Additionally, researchers have discovered that IL-25 maintained intestinal barrier integrity during CDI by inducing the increase of eosinophilia, and restoring the suppressed expression of IL-25 in CDI could decrease mortality and morbidity (Buonomo et al., 2016). This evidence concerns the gene IL25 and clostridium difficile infection.